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In Swiss 3T3 cells, colon tumor-promoting deoxycholate (DOG) enhanced DNA synthesis which was in- 
duced by fibroblast growth factor (FGF) in the presence of insulin. This effect was observed only when 
DOC was added within 10 h after the addition of FGF. DOC by itself did not induce DNA synthesis irre- 
spective of the presence or absence of insulin. Similar results were obtained with other colon tumor-pro- 
moting bile acids such as cholate, chenodeoxycholate and taurocholate. In contrast to these bile acids, 12-O- 
tetradecanoylphorbol-13-acetate (TPA) induced DNA synthesis fully without FGF in the presence of in- 
sulin. DOC did not affect TPA-induced DNA synthesis. Prolonged treatment of the cells with phorbol- 
12,13-dibutyrate caused the down-regulation of the phorbol ester receptor and rendered the cells unrespon- 
sive to TPA. In these cells, FGF still induced DNA synthesis in the presence of insulin, but the maximal 
level was reduced to about one third of that in the control cells. DOC did not enhance this DNA synthesis 
any more. DOC did not alter the binding of FGF to the cells. These results indicate that colon tumor-pro- 
moting bile acids enhance the mitogenic action of FGF and thereby stimulate DNA synthesis, although 
the phorbol ester substitutes for the mitogenic action of FGF. 
Tumor promoter Bile acid Phorbol ester DNA synthesis (Fibroblast) 
1. INTRODUCTION 
Although the initiation-promotion concept of 
tumorigenesis was developed from experiments 
with phorbol esters in mouse skin; recent studies 
have demonstrated that tumor promotion may be 
operative in other tissues (reviews [l-3]). 
Epidemiological studies have suggested that bile 
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Abbreviations: TPA, 12-O-tetradecanoylphorbol- 13- 
acetate; DOC, deoxycholate; FGF, fibroblast growth 
factor; PDBu, phorbol-12,13-dibutyrate; DMEM, 
Dulbecco’s modified Eagle’s medium; FCS, fetal calf 
serum; PDGF, platelet-derived growth factor 
acids derived directly or indirectly from dietary 
factors may be responsible for the etiology of co- 
lon carcinoma [4,5]. Moreover, it has been 
demonstrated experimentally that development of 
colon carcinoma in rat pretreated with some car- 
cinogens was enhanced by administration of bile 
acids to the colon either medically or surgically 
[6-121. Based on these observations, it has been 
proposed that bile acids may serve as tumor pro- 
moters for colon carcinoma [13,14]. 
Although phorbol esters have been shown to af- 
fect a wide variety of biological activities, in- 
cluding stimulation of DNA synthesis and cell pro- 
liferation, induction of cell differentiation, 
stimulation of exocytosis, induction of enzymes 
and stimulation of lipid metabolism [l-3], the 
biological activities of bile acids related to tumor 
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promotion have not yet been clarified except that 
they have been shown to induce ornithine decar- 
boxylase in rat colon [15,16]. Among these 
biological activities of phorbol esters, their 
mitogenic or comitogenic activities are most com- 
monly observed in many types of cells [l-3]. 
Therefore, we investigated the effect of colon 
tumor-promoting bile acids on DNA synthesis in 
Swiss 3T3 fibroblasts, and compared their mode of 
action with that of TPA, one of the most potent 
tumor-promoting phorbol esters [l-3]. 
This paper describes that colon tumor- 
promoting bile acids enhance FGF-induced DNA 
synthesis. This action of the bile acids is totally 
dependent on the growth factor and the bile acids 
by themselves are inactive. This is in marked con- 
trast to the action of TPA which by itself 
substitutes for FGF and induces DNA synthesis. 
To our knowledge, the agonist-dependent action 
of the bile acids has not been described in the 
literature. 
2. MATERiALS AND METHODS 
2.1. materiels and chemicals 
Swiss 3T3 cells, homogeneous bovine pituitary 
FGF and dehydrocholate were kindly supplied by 
Dr E. Rozengurt (Imperial Cancer Research Fund, 
England), Dr D. Gospodarowicz (University of 
California, San Francisco, USA) and Dr K. 
Uchida (Shionogi Research Laboratories, Japan}, 
respectively. TPA and PDBu were obtained from 
CCR. Sodium DOC, cholate, chenodeoxycholate 
and taurocholate were purchased from Difco, 
Wako, Aldrich and Sigma, respectively. Other 
materials and chemicals were obtained from com- 
mercial sources. 
2.2. Cell culture 
Stock cultures of Swiss 3T3 cells were main- 
tained at 37°C in a humidified atmosphere of 10% 
COz:90% air in DMEM containing 10% FCS, 
penicillin (100 units/ml) and streptomycin 
~l~~g/rnl). The cells were subcultured into a 
35 mm dish with the medium containing 10% 
FCS, and refed with the same medium after 2 days. 
Such cultures were used 5 days after the last change 
of the medium. These cells were confluent and 
quiescent. 
154 
2.3. Assay for DNA synthesis 
DNA synthesis was assayed by measuring the in- 
corporation of ~3H]thymidine into DNA by the 
method of Dicker and Rozengurt [17] except that 
the cells were stimulated for 24 h by FGF and ex- 
posed to 2&i [3H]thymidine for 4 h before ter- 
mination of the reaction. When bile acids were 
added to the cells, each bile acid was added to the 
medium during the first 5 h in a 24 h incubation, 
cells washed twice with DMEM and incubation 
continued with the original medium containing 
FCF. 
2.4. bowl-regulation of the ~~or~o~ ester 
receptor 
Quiescent cultures of the cells were incubated 
with DMEM containing 200 nM PDBu and 0.1% 
bovine serum albumin for 24 h as described [ 181. 
Under these conditions, [3H]PDBu-binding activi- 
ty disappeared completely as in [ 181. 
2.5. Assay for FCF binding 
FGF-binding assay was carried out under the 
conditions employed for the PDGF-binding assay 
as in [I91 except that 1251-labeled FGF with a 
specific activity of 1.5 &i/pg was used, Radioac- 
tive FGF was prepared by the method of Bolton 
and Hunter [20]. 
3. RESULTS 
Incubation of quiescent cultures of Swiss 3T3 
cells with various doses of FGF in the presence of 
insulin markedly stimulated DNA synthesis as 
shown in fig. 1. Either FGF or insulin alone 
stimulated this reaction to a small extent. Addition 
of a small amount (1OOpM) of DOC to the cells 
during the first 5 h markedly enhanced DNA syn- 
thesis which was induced by FGF in the presence of 
insulin, particularly at lower doses of FGF. DOC 
did not affect DNA synthesis induced slightly by 
FGF in the absence of insulin. The stimulatory ef- 
fect of DOC on DNA synthesis was dose- 
dependent, and 25-2OOpM DOC was effective in 
this capacity. DOC by itself in any amount 
(25-2OOpM) did not induce DNA synthesis in the 
absence of FGF. Incubation with DOC from the 
5th to 10th hour after stimulation with FGF was 
also effective in stimulating DNA synthesis, but 
the stimulatory effect of DOC was less than that in 
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the cells to which DOC was added during the first 
5 h, as shown in table 1. Addition of DOC, 10 h 
after the initial stimulation with FGF, no longer 
enhanced DNA synthesis. The similar stimulatory 
effect of DOC on FGF-induced DNA synthesis 
- 
Fig.1. Effect of DOC on FGF-induced DNA synthesis. 
Quiescent cultures were stimulated by various doses of 
FGF in the presence or absence of insulin (1 fig/ml). 
DOC (100 PM) was added during the first 5 h. Other 
details are described in section 2. (0) Without DOC in 
the presence of insulin, (0) with DOC in the presence of 
insulin, (A) without DOC in the absence of insulin, (A) 
with DOC in the absence of insulin. Each value is the 
mean of triplicate determinations. 
Table 1 
Chronological analysis of effect of DOC on FGF- 
induced DNA synthesis 
FGF (ng/ml) [3H]Thymidine incorporation into DNA 
(cpm x 10e3) 
Period of, DOC treatment 
None O-5 h S-10 h lo-15 ha 15-20 ha 
0 23.1 22.2 24.8 16.4 15.7 
0.6 130.2 219.4 154.8 92.5 94.6 
1.0 218.3 260.5 242.4 143.4 152.9 
3.0 247.3 266.1 250.2 217.0 209.7 
a These experimental values were slightly lower than 
those of the control experiments. This was due to some 
toxic effects of DOC which detached part of the cells 
from the dishes during these periods 
Quiescent cultures were stimulated by the indicated 
doses of FGF in the presence of insulin (l/g/ml). DOC 
(lOOaM) was added in the indicated 5 h period in the 
24 h incubation. Other details are described in section 2. 
Each value is the mean of triplicate determinations 
Table 2 
Effect of various bile acids on FGF-induced DNA synthesis 
Bile acids [3H]Thymidine incorporation into DNA 
(cpm x 10m3) 
None FGF FGF FGF 
(0.6 ng/ml) (1.0 ng/ml) (3.0 ng/ml) 
None 23.1 130.2 218.3 247.3 
Deoxycholate 22.2 219.4 260.5 266.1 
Cholate 23.0 190.7 263.3 250.0 
Chenodeoxycholate 21.2 209.3 275.0 269.2 
Taurocholate 24.0 203.3 261.2 270.1 
Dehydrocholate 20.2 141.0 208.2 243.8 
Quiescent cultures were stimulated by indicated doses of FGF in the 
presence of insulin (1 pg/ml). Each bile acid (100 PM) was added 
during the first 5 h. Other details are described in section 2. Each 
value is the mean of triplicate determinations 
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Fig.2. Effect of DOC on TPA-induced DNA synthesis. 
mean of triplicate determinations. 
Quiescent cultures were stimulated by various doses of 
TPA in the presence or absence of insulin (1 pg/ml). 
DOC (100/1M) was added during the first 5 h. Other 
details are described in section 2. (0) Without DOC in 
the presence of insulin, (0) with DOC in the presence of 
insulin, (A) without DOC in the absence of insulin, (A) 
with DOC in the absence of insulin. Each value is the 
was also observed with other colon tumor- 
promoting bile acids such as cholate, chenodeox- 
ycholate and taurocholate as shown in table 2. 
Dehydrocholate, which is inactive in induction of 
ornithine decarboxylase in rat colonic epithelia 
[15], was ineffective at stimulating DNA synthesis. 
In contrast to the bile acids, TPA by itself 
stimulated DNA synthesis without FGF in the 
presence of insulin as shown in fig.2. DOC did not 
affect TPA-induced DNA synthesis. Moreover, 
treatment of the cells with PDBu for 24 h caused 
I I 
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Fig.3. Effect of DOC on FGF-induced DNA synthesis in 
cells pretreated with PDBu. Quiescent cultures were 
is the mean of triplicate determinations. 
treated with or without PDBu (200 nM) at 37°C for 
24 h. After washing with DMEM, the cultures were 
stimulated by various doses of FGF in the presence of 
insulin (1 pg/ml). DOC (1OOpM) was added during the 
first 5 h. Other details are described in section 2. (0) In 
the absence of DOC without PDBu pretreatment, (0) in 
the presence of DOC without PDBu pretreatment, (A) in 
the absence of DOC with PDBu pretreatment, (A) in the 
presence of DOC with PDBu pretreatment. Each value 
the down-regulation and complete disappearance 
of the phorbol ester receptor and rendered the cells 
unresponsive to TPA as described in [ 181. In these 
cells, TPA no longer induced DNA synthesis, but 
FGF still induced DNA synthesis although the level 
of this reaction was reduced to about one third of 
that in the control cells. DOC did not enhance 
FGF-induced DNA synthesis in these cells as 
shown in fig.3. 
In the last set of experiments, the effect of DOC 
on FGF binding to the cells was examined. As 
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Fig.4. Effect of DOC on ‘ZSI-FGF binding to the cells. 
Quiescent cultures were incubated for 60 min at 37°C 
with various doses of “‘1-FGF in the presence or 
absence of DOC (100 PM). Other details are described in 
section 2. Specific binding was calculated by subtraction 
of nonspecific binding from total binding. Nonspecific 
binding was defined as tracer binding in the presence of 
500 ng/ml of unlabeled FGF and about 60-70% of total 
binding. (0) Specific binding without DOC, (0) specific 
binding with DOC. Each value is the mean of triplicate 
determinations. 
shown in fig.4, 12’1-labeled FGF bound to the cells 
in a dose-dependent manner. DOC (100 PM) did 
not show any effect on this binding of FGF (fig.4). 
4. DISCUSSION 
Our results clearly indicate that, although bile 
acids by themselves are not mitogenic, they 
enhance FGF-induced, insulin-dependent DNA 
synthesis. This action is in marked contrast to that 
of TPA. TPA is able to induce DNA synthesis even 
without FGF. Although it is not known whether 
the stimulatory effect of bile acids on DNA syn- 
thesis is related to their action as detergents, this 
effect is not nonspecific since bile acids affect 
neither TPA-induced DNA synthesis nor the bind- 
ing of FGF to the cells. We have also confirmed 
that incubation with 100 PM DOC for 5 h does not 
destroy the cells as judged by a trypan blue exclu- 
sion test, although incubation with the same 
amount of DOC for more than 5 h or incubation 
with DOC in amounts higher than 200 PM for 5 h 
shows toxic effects on the cells. 
FGF as well as PDGF has been demonstrated to 
serve as a ‘competence factor’ in Balb/c 3T3 cells 
[21]. On the other hand, insulin as well as 
somatomedin C has been shown to be a ‘progres- 
sion factor’ [22]. The competence factor renders 
the cells ‘competent’ to leave the Go phase of the 
cell cycle to enter the Gr phase, whereas the pro- 
gression factor is essential for the cells, which have 
become competent, to progress to enter the S 
phase. Since bile acids enhance FGF-induced DNA 
synthesis when added within 10 h after the initial 
stimulation with FGF and are inactive when added 
more than 10 h after the initial stimulation of 
FGF, these results strongly suggest hat bile acids 
may potentiate the action of the competence factor 
rather than that of the progression factor. 
We have recently obtained evidence that FGF in- 
duces phosphoinositide turnover and subsequent 
activation of protein kinase C as described for 
PDGF in Swiss 3T3 cells [23]. Another line of 
evidence indicates that a phorbol ester receptor 
may be protein kinase C itself and diverse effects 
of phorbol esters may be mediated through the ac- 
tivation of this enzyme [24-271. Here, it is shown 
that (i) bile acids enhance FGF-induced DNA syn- 
thesis but do not enhance TPA-induced DNA syn- 
thesis; (ii) bile acids do not enhance FGF-induced 
DNA synthesis in the cells in which the phorbol 
ester receptor, namely protein kinase C, is down- 
regulated by pretreatment with PDBu; (iii) bile 
acids do not affect the binding of FGF to the cells. 
These results suggest that bile acids may act on 
post-receptor and pre-protein kinase C site(s), 
presumably via the activation of protein kinase C 
by diacylglycerol. This possibility is now under in- 
vestigation in our laboratories. 
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